Corrigendum to "Investigation of biomarkers for azole antifungal-induced liver injury using primary human hepatocyte spheroids" [Drug Metabolism and Disposition 54 (2026) 100343].

IF 3.6 3区医学 Q1 PHARMACOLOGY & PHARMACY

Drug Metabolism and Disposition Pub Date : 2026-08-01 DOI:10.1016/j.dmd.2026.100377

Masaki Kumondai, Ayaka Yagi, Masahiro Watanabe, Yanlin Lyu, Ryosuke Segawa, Mayumi Sato, Ryo Tadakuma, Kenji Inoue, Hideki Watanabe, Masahiro Takeda, Yoshiteru Ohshima, Masamitsu Maekawa, Nariyasu Mano

引用次数: 0

查看原文本刊更多论文

“用原代人肝细胞球体研究唑类抗真菌诱导肝损伤的生物标志物”[药物代谢与处置54(2026)100343]的勘误表。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Drug Metabolism and Disposition 医学-药学

CiteScore

6.50

自引率

12.80%

发文量

128

审稿时长

3 months

期刊介绍： An important reference for all pharmacology and toxicology departments, DMD is also a valuable resource for medicinal chemists involved in drug design and biochemists with an interest in drug metabolism, expression of drug metabolizing enzymes, and regulation of drug metabolizing enzyme gene expression. Articles provide experimental results from in vitro and in vivo systems that bring you significant and original information on metabolism and disposition of endogenous and exogenous compounds, including pharmacologic agents and environmental chemicals.